Maintenance: Thursday, 21 September 2017, 18h00-18h30
Maintenance work on the ZORA servers is provided. There may be short interruptions in the service between 18:00 and 18:30. Thank you for your patience.
Gerber, B; Eichenberger, S; Joller-Jemelka, H I; Wittenbrink, M M; Reusch, C E (2010). Complement C3 in Bernese Mountain dogs. Veterinary Clinical Pathology, 39(2):164-168.
Böni, J; Bisset, L R; Burckhardt, J J; Joller-Jemelka, H I; Bürgisser, P; Perrin, L; Gorgievski, M; Erb, P; Fierz, W; Piffaretti, J C; Schüpbach, J (2004). Prevalence of human T-cell leukemia virus types I and II in Switzerland. Journal of Medical Virology, 72(2):328-337.
Opravil, M; Pechère, M; Speich, R; Joller-Jemelka, H I; Jenni, R; Russi, E W; Hirschel, B; Lüthy, R (1997). HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. American Journal of Respiratory and Critical Care Medicine, 155(3):990-995.
Rajan, G P; Seifert, Burkhardt; Prümmer, O; Joller-Jemelka, H I; Burg, G; Dummer, R (1996). Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA. Archives of Dermatological Research, 288(9):543-8.
Studer, S; Joller-Jemelka, H I; Steffen, Robert; Grob, P J (1993). Prevalence of hepatitis A antibodies in Swiss travellers. European Journal of Epidemiology, 9(1):50-54.